Friedhelm Raue

Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: March 19, 2025

Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: March 19, 2025

Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: March 19, 2025

What Is New in Diagnostics and Management of Medullary Thyroid Carcinoma.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: March 19, 2025

Medullary Thyroid Carcinoma: Imaging.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: March 19, 2025

The Long-Term Cure of Patients With Hereditary Medullary Thyroid Carcinoma: 40 Years of Follow-Up in a Single Center.

Journal: Deutsches Arzteblatt international

Published: April 18, 2024

Thyroid Dysfunction in Periand Postmenopausal Women-Cumulative Risks.

Journal: Deutsches Arzteblatt international

Published: November 02, 2022

Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry Analysis.

Journal: Cancers

Published: May 05, 2022

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.

Journal: Clinical endocrinology

Published: July 22, 2021

Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma.

Journal: Clinical chemistry and laboratory medicine

Published: April 12, 2021

Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.

Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.

Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.

Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.

Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients.

Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients.

What Is New in Diagnostics and Management of Medullary Thyroid Carcinoma.

What Is New in Diagnostics and Management of Medullary Thyroid Carcinoma.

Medullary Thyroid Carcinoma: Imaging.

Medullary Thyroid Carcinoma: Imaging.

The Long-Term Cure of Patients With Hereditary Medullary Thyroid Carcinoma: 40 Years of Follow-Up in a Single Center.

The Long-Term Cure of Patients With Hereditary Medullary Thyroid Carcinoma: 40 Years of Follow-Up in a Single Center.

Thyroid Dysfunction in Periand Postmenopausal Women-Cumulative Risks.

Thyroid Dysfunction in Periand Postmenopausal Women-Cumulative Risks.

Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry Analysis.

Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry Analysis.

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.

Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma.

Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma.

Title Not Found

Title Not Found

Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma.

Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma.